Uncontrolled asthma in texans led to more than 1-hundred 15-thousand emergency department visits in 20-18 -- according to texas health and human services.Dr. Am ...

AZN's key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected to have driven the company's top line.

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

“Fasenra offers a more targeted approach to treatment. With its innovative mechanism of action and established success in asthma, Fasenra could address critical safety and efficacy ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender for market share in ... As the COPD market continues to evolve, biologics are ...

Space limited. Register now. Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental More than 90 percent of adults aged 65 and older take at least one prescription medication, ...

The journey of mental health treatment has been a fascinating evolution. For much of modern history, psychotherapy was the primary method for addressing mental health struggles. While therapy ...

Asthma medications such as albuterol work by increasing cAMP levels in airway smooth muscle cells, causing them to relax and airways to open. "By targeting the newly discovered transporter ...

Beyond diagnosis, the discovery of the cAMP transporter mechanism could lead to new therapeutic approaches. Asthma medications such as albuterol work by increasing cAMP levels in airway smooth muscle ...

or other nonsteroidal anti-inflammatory medications (NSAIDs) if you are taking any other blood thinners or have any of these conditions — bleeding problems, asthma, recent or upcoming surgery ...

Additionally, she said assets like Breztri (budesonide + formoterol fumarate + glycopyrrolate) and Fasenra (benralizumab) are positioned for indication expansion into severe asthma and chronic ...